Glycopeptide resistance in gram-positive Cocci: A review

Interdisciplinary Perspectives on Infectious Diseases

Volumn 2012, Issue , 2012, Pages

  Sujatha, S ^a   Praharaj, Ira ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; PEPTIDOGLYCAN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENETICS; BACTERIUM ISOLATE; BASE MISPAIRING; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG TOLERANCE; GENE CLUSTER; GENOTYPE; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84863661835     PISSN: 1687708X     EISSN: 16877098     Source Type: Journal    
DOI: 10.1155/2012/781679     Document Type: Review

References (85)

1. Murray B. E., Nannini E. C., Mandell G. L., Bennet J. E., Dolin R., Glycopeptides (Vancomycin and Teicoplanin), Streptogramins(Quinupristin- Dalfopristin), and Lipopeptides (Daptomycin) Principles and Practice of Infectious Diseases 2010 7th Philadelphia, Pa, USA Churchill Livingstone 449 468
2. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F. C., Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility Journal of Antimicrobial Chemotherapy 1997 40 1 135 136 (Pubitemid 27341646)
3. Cetinkaya Y., Falk P., Mayhall C. G., Vancomycin-resistant enterococci Clinical Microbiology Reviews 2000 13 4 686 707
4. Lebreton F., Depardieu F., Bourdon N., Fines-Guyon M., Berger P., Camiade S., Leclercq R., Courvalin P., Cattoir V., D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium Antimicrobial Agents and Chemotherapy 2011 55 10 4606 4612
5. Courvalin P., Vancomycin resistance in gram-positive cocci Clinical Infectious Diseases 2006 42 1 S25 S34
6. Boyd D. A., Willey B. M., Fawcett D., Gillani N., Mulvey M. R., Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL Antimicrobial Agents and Chemotherapy 2008 52 7 2667 2672 (Pubitemid 351915706)
7. Xu X., Lin D., Yan G., Ye X., Wu S., Guo Y., Zhu D., Hu F., Zhang Y., Wang F., Jacoby G. A., Wang M., vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium Antimicrobial Agents and Chemotherapy 2010 54 11 4643 4647
8. Uttley A. H. C., George R. C., Naidoo J., Woodford N., Johnson A. P., Collins C. H., Morrison D., Gilfillan A. J., Fitch L. E., Heptonstall J., High-level vancomycin-resistant enterococci causing hospital infections Epidemiology and Infection 1989 103 1 173 181 (Pubitemid 19223468)
9. Arthur M., Courvalin P., Genetics and mechanisms of glycopeptide resistance in enterococci Antimicrobial Agents and Chemotherapy 1993 37 8 1563 1571 (Pubitemid 23226362)
10. Perichon B., Reynolds P., Courvalin P., VanD-type glycopeptide-resistant Enterococcus faecium BM4339 Antimicrobial Agents and Chemotherapy 1997 41 9 2016 2018 (Pubitemid 27383248)
11. McKessar S. J., Berry A. M., Bell J. M., Turnidge J. D., Paton J. C., Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis Antimicrobial Agents and Chemotherapy 2000 44 11 3224 3228
12. Cooper M. A., Fiorini M. T., Abell C., Williams D. H., Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers Bioorganic and Medicinal Chemistry 2000 8 11 2609 2616
13. Reynolds P. E., Courvalin P., Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-Alanyl-D-Serine Antimicrobial Agents and Chemotherapy 2005 49 1 21 25 (Pubitemid 40065767)
14. Bager F., Madsen M., Christensen J., Aarestrup F. M., Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms Preventive Veterinary Medicine 1997 31 1-2 95 112 (Pubitemid 127414652)
15. van den Bogaard A. E., Bruinsma N., Stobberingh E. E., The effect of banning avoparcin on VRE carriage in The Netherlands Journal of Antimicrobial Chemotherapy 2000 46 1 146 148 (Pubitemid 30466214)
16. Depardieu F., Kolbert M., Pruul H., Bell J., Courvalin P., VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis Antimicrobial Agents and Chemotherapy 2004 48 10 3892 3904 (Pubitemid 39304619)
17. Dever L. L., Smith S. M., Handwerger S., Eng R. H. K., Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy Journal of Clinical Microbiology 1995 33 10 2770 2773
18. Murray B. E., Nannini E. C., Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), and Lipopeptides (Daptomycin). 2010
19. Arthur M., Quintiliani R., Regulation of VanA- and VanB-type glycopeptide resistance in enterococci Antimicrobial Agents and Chemotherapy 2001 45 2 375 381 (Pubitemid 32105270)
20. CLSI, Performance Standards for Antimicrobial Susceptibility Testing. Twentieth Informational Supplement, 2010
21. Willey B. M., Kreiswirth B. N., Simor A. E., Williams G., Scriver S. R., Phillips A., Low D. E., Detection of vancomycin resistance in Enterococcus species Journal of Clinical Microbiology 1992 30 7 1621 1624
22. Murray P. K., Baron E. J., Landry M. L., Jorgensen J. H., Pfaller M. A., Manual of Clinical Microbiology 2007 9th ASM Press
23. Kohner P. C., Patel R., Uhl J. R., Garin K. M., Hopkins M. K., Wegener L. T., Cockerill F. R., Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin Journal of Clinical Microbiology 1997 35 12 3258 3263 (Pubitemid 27505755)
24. Swenson J. M., Clark N. C., Ferraro M. J., Sahm D. F., Doern G., Pfaller M. A., Reller L. B., Weinstein M. P., Zabransky R. J., Tenover F. C., Development of a standardized screening method for detection of vancomycin-resistant enterococci Journal of Clinical Microbiology 1994 32 7 1700 1704 (Pubitemid 24189559)
25. Swenson J. M., Clark N. C., Sahm D. F., Ferraro M. J., Doern G., Hindler J., Jorgensen J. H., Pfaller M. A., Reller L. B., Weinstein M. P., Zabransky R. J., Tenover F. C., Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci Journal of Clinical Microbiology 1995 33 11 3019 3021
26. CLSI, Performance Standards for Antimicrobial Susceptibility Testing 2008 18th CLSI
27. Carroll K. C., Borek A. P., Burger C., Glanz B., Bhally H., Henciak S., Flayhart D. C., Evaluation of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci Journal of Clinical Microbiology 2006 44 6 2072 2077 (Pubitemid 43902155)
28. Malhotra-Kumar S., Haccuria K., Michiels M., Ieven M., Poyart C., Hryniewicz W., Goossens H., Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant Enterococcus Species Journal of Clinical Microbiology 2008 46 5 1577 1587 (Pubitemid 351657198)
29. Facklam R. R., Carvalho M. G. S., Texeira L. M., History, taxonomy, biochemical characteristics, and antibiotic susceptibility testing of enterococci The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance 2002 ASM Press 1 54
30. Kariyama R., Mitsuhata R., Chow J. W., Clewell D. B., Kumon H., Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci Journal of Clinical Microbiology 2000 38 8 3092 3095 (Pubitemid 30640606)
31. Dutka-Malen S., Evers S., Courvalin P., Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR Journal of Clinical Microbiology 1995 33 1 24 27 (Pubitemid 24382391)
32. Patel R., Uhl J. R., Kohner P., Hopkins M. K., Cockerill F. R., Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in Enterococci Journal of Clinical Microbiology 1997 35 3 703 707 (Pubitemid 27083865)
33. Depardieu F., Perichon B., Courvalin P., Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR Journal of Clinical Microbiology 2004 42 12 5857 5860 (Pubitemid 39664379)
34. Palladino S., Kay I. D., Costa A. M., Lambert E. J., Flexman J. P., Real-time PCR for the rapid detection of vanA and vanB genes Diagnostic Microbiology and Infectious Disease 2003 45 1 81 84 (Pubitemid 36165035)
35. Auckland C., Teare L., Cooke F., Kaufmann M. E., Warner M., Jones G., Bamford K., Ayles H., Johnson A. P., Linezolid-resistant enterococci: report of the first isolates in the United Kingdom Journal of Antimicrobial Chemotherapy 2002 50 5 743 746 (Pubitemid 35331695)
36. Rahim S., Pillai S. K., Gold H. S., Venkataraman L., Inglima K., Press R. A., Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid Clinical Infectious Diseases 2003 36 11 E146 E148
37. Kainer M. A., Devasia R. A., Jones T. F., Simmons B. P., Melton K., Chow S., Broyles J., Moore K. L., Craig A. S., Schaffner W., Response to emerging infection leading to outbreak of linezolid-resistant enterococci Emerging Infectious Diseases 2007 13 7 1024 1030 (Pubitemid 47048074)
38. Winston D. J., Emmanouilides C., Kroeber A., Hindler J., Bruckner D. A., Territo M. C., Busuttil R. W., Quinupristin/dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium Clinical Infectious Diseases 2000 30 5 790 797
39. Eliopoulos G. M., Wennersten C. B., Gold H. S., Schlin T., Souli M., Farris M. G., Cerwinka S., Nadler H. L., Dowzicky M., Talbot G. H., Moellering R. C., Characterization of vancomycin-resistant Enterococcus faecium isolates from the united states and their susceptibility in vitro to dalfopristin- quinupristin Antimicrobial Agents and Chemotherapy 1998 42 5 1088 1092 (Pubitemid 28227902)
40. Freeman C., Robinson A., Cooper B., Mazens-Sullivan M., Quintiliani R., Nightingale C., In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci Diagnostic Microbiology and Infectious Disease 1995 21 1 47 50
41. Angulo F., Marano M., Mackinson C., Isolation of quinupristin/ dalfopristin-resistant Enterococcus faecium from human stool specimens and retail chicken products in the US-associated with use of virginiamycin in poultry. 2000
42. Johnson A. P., Warner M., Hallas G., Livermore D. M., Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999 Journal of Antimicrobial Chemotherapy 2000 46 1 125 128 (Pubitemid 30466208)
43. Cantn R., Ruiz-Garbajosa P., Chaves R. L., Johnson A. P., A potential role for daptomycin in enterococcal infections: what is the evidence? Journal of Antimicrobial Chemotherapy 2010 65 6 1126 1136
44. Mathai D., Biedenbach D. J., Jones R. N., Bell J. M., Turnidge J., Sader H. S., Activity of daptomycin against Gram-positive bacterial isolates from Indian medical centres (2006-2007) International Journal of Antimicrobial Agents 2009 34 5 497 499
45. Kosowska-Shick K., Clark C., Pankuch G. A., McGhee P., Dewasse B., Beachel L., Appelbaum P. C., Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies Antimicrobial Agents and Chemotherapy 2009 53 10 4217 4224
46. Florescu I., Beuran M., Dimov R., Razbadauskas A., Bochan M., Fichev G., Dukart G., Babinchak T., Cooper C. A., Ellis-Grosse E. J., Dartois N., Gandjini H., Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study The Journal of antimicrobial chemotherapy 2008 62 i17 i28
47. Menezes G. A., Harish B. N., Sujatha S., Vinothini K., Parija S. C., Emergence of vancomycin-intermediate Staphylococcus species in southern India Journal of Medical Microbiology 2008 57 7 911 912
48. Appelbaum P. C., The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus Clinical Microbiology and Infection 2006 12 1 16 23
49. Howden B. P., Davies J. K., Johnson P. D. R., Stinear T. P., Grayson M. L., Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications Clinical Microbiology Reviews 2010 23 1 99 139
50. Muthaiyan A., Jayaswal R. K., Wilkinson B. J., Intact mutS in laboratory-derived and clinical glycopeptide-intermediate Staphylococcus aureus strains Antimicrobial Agents and Chemotherapy 2004 48 2 623 625 (Pubitemid 38141728)
51. Chang S., Sievert D. M., Hageman J. C., Boulton M. L., Tenover F. C., Downes F. P., Shah S., Rudrik J. T., Pupp G. R., Brown W. J., Cardo D., Fridkin S. K., Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene New England Journal of Medicine 2003 348 14 1342 1347 (Pubitemid 36384101)
52. Périchon B., Courvalin P., VanA-type vancomycin-resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy 2009 53 11 4580 4587
53. Chakraborty S. P., KarMahapatra S., Bal M., Roy S., Isolation and Identification of Vancomycin Resistant Staphylococcus aureus from Post Operative Pus Sample Al Ameen Journal of Medical Science 2011 4 2 152 168
54. Saha B., Singh A. K., Ghosh A., Bal M., Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia) Journal of Medical Microbiology 2008 57 1 72 79
55. Weigel L. M., Clewell D. B., Gill S. R., Clark N. C., McDougal L. K., Flannagan S. E., Kolonay J. F., Shetty J., Killgore G. E., Tenover F. C., Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus Science 2003 302 5650 1569 1571 (Pubitemid 37475701)
56. Tenover F. C., Moellering R. C., The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus Clinical Infectious Diseases 2007 44 9 1208 1215 (Pubitemid 46651246)
57. Wootton M., Howe R. A., Hillman R., Walsh T. R., Bennett P. M., MacGowan A. P., A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital Journal of Antimicrobial Chemotherapy 2001 47 4 399 403 (Pubitemid 32303403)
58. Riederer K., Shemes S., Chase P., Musta A., Mar A., Khatib R., Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of etest and agar screening methods Journal of Clinical Microbiology 2011 49 6 2147 2150
59. Fox P. M., Lampen R. J., Stumpf K. S., Archer G. L., Climo M. W., Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and -lactam antibiotics Antimicrobial Agents and Chemotherapy 2006 50 9 2951 2956 (Pubitemid 44396397)
60. Hiramatsu K., Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance Lancet Infectious Diseases 2001 1 3 147 155 (Pubitemid 33586048)
61. Cui L., Tominaga E., Neoh H. M., Hiramatsu K., Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus Antimicrobial Agents and Chemotherapy 2006 50 3 1079 1082 (Pubitemid 43327815)
62. Saravolatz L., Pawlak J., Johnson L., In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, and daptomycin-nonsusceptible Staphylococcus aureus isolates Antimicrobial Agents and Chemotherapy 2010 54 7 3027 3030
63. Schwalbe R. S., Stapleton J. T., Gilligan P. H., Emergence of vancomycin resistance in coagulase-negative staphylococci New England Journal of Medicine 1987 316 15 927 931 (Pubitemid 17041985)
64. Biavasco F., Vignaroli C., Varaldo P. E., Glycopeptide resistance in coagulase-negative staphylococci European Journal of Clinical Microbiology and Infectious Diseases 2000 19 6 403 417 (Pubitemid 30458648)
65. Srinivasan A., Dick J. D., Perl T. M., Vancomycin resistance in Staphylococci Clinical Microbiology Reviews 2002 15 3 430 438 (Pubitemid 34761351)
66. Natoli S., Fontana C., Favaro M., Bergamini A., Testore G. P., Minelli S., Bossa M. C., Casapulla M., Broglio G., Beltrame A., Cudillo L., Cerretti R., Leonardis F., Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options BMC Infectious Diseases 2009 9, article no. 83
67. Tacconelli E., Tumbarello M., De Gaetano Donati K., Bettio M., Spanu T., Leone F., Sechi L. A., Zanetti S., Fadda G., Cauda R., Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study Clinical Infectious Diseases 2001 33 10 1628 1635 (Pubitemid 33044525)
68. Ma X. X., Wang E. H., Liu Y., Luo E. J., Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin non-susceptible CoNS strains with inducible resistance to vancomycin Journal of Medical Microbiology 2011 60 1661 1668
69. Billot-Klein D., Gutmann L., Bryant D., Bell D., Van Heijenoort J., Grewal J., Shlaes D. M., Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics Journal of Bacteriology 1996 178 15 4696 4703 (Pubitemid 26262260)
70. Sanyal D., Johnson A. P., George R. C., Edwards R., Greenwood D., In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD Journal of Antimicrobial Chemotherapy 1993 32 2 267 278 (Pubitemid 23272311)
71. Krcmery V., Trupl J., Spanik S., Bacteremia due to teicoplanin-resistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin Infection 1997 25 1 51 52 (Pubitemid 27075663)
72. Sieradzki K., Roberts R. B., Serur D., Hargrave J., Tomasz A., Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy Journal of Clinical Microbiology 1999 37 1 39 44 (Pubitemid 29004177)
73. Paiva R. M., Mombach Pinheiro Machado A. B., Zavascki A. P., Barth A. L., Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and etest methods Journal of Clinical Microbiology 2010 48 12 4652 4654
74. Raney P. M., Williams P. P., McGowan J. E., Tenover F. C., Validation of Vitek version 7.01 software for testing staphylococci against vancomycin Diagnostic Microbiology and Infectious Disease 2002 43 2 135 140 (Pubitemid 34667085)
75. May J., Shannon K., King A., French G., Glycopeptide tolerance in Staphylococcus aureus Journal of Antimicrobial Chemotherapy 1998 42 2 189 197 (Pubitemid 28393587)
76. Chenoweth C. E., Saint S., Martinez F., Lynch J. P., Mark Fendrick A., Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia Mayo Clinic Proceedings 2000 75 11 1161 1168
77. Normark B. H., Normark S., Antibiotic tolerance in pneumococci Clinical Microbiology and Infection 2002 8 10 613 622 (Pubitemid 35277116)
78. McCullers J. A., English B. K., Novak R., Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis Journal of Infectious Diseases 2000 181 1 369 373 (Pubitemid 30049073)
79. Novak R., Henriques B., Charpentier E., Normark S., Tuomanen E., Emergence of vancomycin tolerance in Streptococcus pneumoniae Nature 1999 399 6736 590 593
80. Moscoso M., Domenech M., Garca E., Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide Molecular Microbiology 2010 77 4 1052 1064
81. Boost M. V., Ko W. M., O'Donoghue M. M., Penicillin and vancomycin tolerance among clinical isolates of Streptococcus pneumoniae in Hong Kong Hong Kong Medical Journal 2003 9 6 415 418 (Pubitemid 37553360)
82. Hidalgo M., Castaeda E., Arias C. A., Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy 2003 52 2 300 302 (Pubitemid 36986897)
83. Sung H., Hee B. S., Kim M.-N., Lee K., Kim E.-C., Song W., Seok H. J., Lee W.-G., Park Y.-J., Eliopoulos G. M., Vancomycin-tolerant Streptococcus pneumoniae in Korea Journal of Clinical Microbiology 2006 44 10 3524 3528 (Pubitemid 46768777)
84. Decousser J. W., Pina P., Viguier F., Picot F., Courvalin P., Allouch P., Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002 Antimicrobial Agents and Chemotherapy 2004 48 9 3636 3639 (Pubitemid 39129380)
85. Antn N., Blzquez R., Gmez-Garcés J. L., Als J. I., Study of vancomycin tolerance in 120 strains of Streptococcus pneumoniae isolated in 1999 in Madrid, Spain Journal of Antimicrobial Chemotherapy 2001 47 6 902 903